Cargando…
Data-driven translational prostate cancer research: from biomarker discovery to clinical decision
Prostate cancer (PCa) is a common malignant tumor with increasing incidence and high heterogeneity among males worldwide. In the era of big data and artificial intelligence, the paradigm of biomarker discovery is shifting from traditional experimental and small data-based identification toward big d...
Autores principales: | Lin, Yuxin, Zhao, Xiaojun, Miao, Zhijun, Ling, Zhixin, Wei, Xuedong, Pu, Jinxian, Hou, Jianquan, Shen, Bairong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060655/ https://www.ncbi.nlm.nih.gov/pubmed/32143723 http://dx.doi.org/10.1186/s12967-020-02281-4 |
Ejemplares similares
-
Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey
por: Lin, Yuxin, et al.
Publicado: (2021) -
Comparison of MRI/US Fusion Targeted Biopsy and Systematic Biopsy in Biopsy-Naïve Prostate Patients with Elevated Prostate-Specific Antigen: A Diagnostic Study
por: Huang, Chen, et al.
Publicado: (2022) -
New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3
por: Huang, Chen, et al.
Publicado: (2022) -
A novel clinically significant prostate cancer prediction system with multiparametric MRI and PSA: P.Z.A. score
por: Chen, Zongxin, et al.
Publicado: (2023) -
Multivariate competing endogenous RNA network characterization for cancer microRNA biomarker discovery: a novel bioinformatics model with application to prostate cancer metastasis
por: Lin, Yuxin, et al.
Publicado: (2022)